Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and make those costs more transparent.
In a report released on January 29, Whit Mayo from Leerink Partners reiterated a Hold rating on Amedisys (AMED – Research Report), with a price ...
A San Francisco police officer was recognized Wednesday as Officer of the Month for aiding in the capture of the man suspected of fatally shooting a health care company CEO in New ...
Oregon Health & Science University warned 74,000 patients covered by UnitedHealthcare that they may lose access to OHSU ...
Jan 30 (Reuters) - Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong ...
Tuong Van Bui, DO, family medicine physician for Southwest Medical, part of Optum talks about the importance of annual wellness visits, staying up to date with vaccinations and regular health ...
Quest Diagnostics is a leading provider of independent diagnostic testing in the United States thanks to its network of roughly 2,300 patient service centers across the country. We think its size and ...
Shares of Cigna Group slipped 6.70% to $282.98 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.53% to 6,071.17 and the Dow ...
Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...
An analysis from health policy charity Kaiser Family Foundation (KFF) evaluated nearly 400million claims made to insurance ...
Cigna executives kicked off Thursday’s earnings call by responding to pharmacy benefit manager critics with a number of reforms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback